Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
08/2014
08/12/2014US8802193 Vapor deposition of biomolecules
08/12/2014US8802162 L-citrulline for treating endothelial dysfunction and erectile dysfunction
08/12/2014US8802153 System for targeted delivery of therapeutic agents
08/12/2014US8802148 Microparticles and method for their production
08/12/2014US8802123 Endosseous implant
08/12/2014US8802115 Solid forms for tissue repair
08/12/2014US8802107 VEGF antagonist formulations for intravitreal administration
08/12/2014US8802106 Peptide compositions and methods for inhibiting herpesvirus infection
08/12/2014US8802104 Parathyroid hormone receptor activation and stem and progenitor cell expansion
08/12/2014US8802099 Methods to treat allergic conditions
08/12/2014US8802091 Antibodies reactive with B7-H3 and uses thereof
08/12/2014US8802088 Mixture of peptide-bound tryptophan and polypeptide-bound tryptophan
08/12/2014US8802087 Pharmaceutical compositions of lipase-containing products, in particular of pancreation
08/12/2014US8802086 Methods of disinfecting packages in aseptic packaging using antimicrobial peracid compositions with selected catalase enzymes
08/12/2014US8802085 Compositions for topical treatment of medical conditions including wounds and inflammation
08/12/2014US8802084 ACE2 activation for treatment of heart, lung and kidney disease and hypertension
08/12/2014US8802076 Compositions and methods for modulating an immune response
08/12/2014US8801955 Water-soluble nanoparticles stabilized with multi-functional group ligands and method of preparation thereof
08/12/2014CA2689016C Melanocortin receptor ligands modified with hydantoin
08/12/2014CA2586735C Antitumor combinations containing a vegf inhibitor and 5fu or one of its derivatives
08/12/2014CA2543255C Methods and compositions for regenerating connective tissue
08/12/2014CA2520392C Covalent attachment of ligands to nucleophilic proteins guided by non-covalent binding
08/12/2014CA2509666C Methods and compositions using compounds from fetal cells and tissues to improve condition of skin
08/12/2014CA2490572C Pig binding protein from adipocytes
08/12/2014CA2482893C Modification of the properties of a fibrin matrix with respect to growth and ingrowth of cells
08/12/2014CA2343223C Anti-inflammatory and antimicrobial uses for bioactive glass compositions
08/07/2014WO2014121303A1 Mechanochemical collagen assembly
08/07/2014WO2014121228A1 Methods of controlling vascularity using raver2 as a mediator for expression of vegf receptor sfit1
08/07/2014WO2014121210A1 Methods for producing diketopiperazines and compositions containing diketopiperazines
08/07/2014WO2014121155A1 Methods of treating iron deficiency with soluble ferric pyrophosphate
08/07/2014WO2014120770A1 Cystathionine beta-synthase enzyme for treatment of homocystinuria
08/07/2014WO2014120714A1 Compositions and methods for the expansion of stem cells
08/07/2014WO2014120619A2 Compositions and methods of use in treating metabolic disorders
08/07/2014WO2014120026A1 Treatment and prevention of acne
08/07/2014WO2014119953A1 A method of virus inactivation in composition comprising factor vii
08/07/2014WO2014119836A1 Pharmaceutical composition for protecting wounds, providing hemostasis, or preventing adhesion in the gastrointestinal tract
08/07/2014WO2014119823A1 Pharmaceutical composition for reducing or inhibiting scar formation, containing bmp-7 and diluting agent
08/07/2014WO2014118785A1 Generation of cytotoxic tumor specific cell lines and uses thereof
08/07/2014WO2014118774A1 Pharmaceutical compositions for oral treatment of diabetes
08/07/2014WO2014118677A1 Compositions and methods for counteracting factor xa inhibition
08/07/2014WO2014118552A1 Inhibition of the complement system
08/07/2014WO2014118355A1 Stabilized pharmaceutical formulations of insulin analogues and/or insulin derivatives
08/07/2014WO2014118296A1 Methods for treating mitochondrial disorders and neurodegenerative disorders
08/07/2014WO2014118271A1 Compositions for oral administration having a beneficial effect on cartilage disease, osteoarthritis and joint disease with an inflammatory component
08/07/2014WO2014118180A1 Crystalline form of linaclotide
08/07/2014WO2014117755A1 Antibiotic preparation and use thereof
08/07/2014WO2014089169A3 Immunotherapy with binding agents
08/07/2014WO2013049697A9 Aromatic-cationic peptides and methods for using same
08/07/2014US20140221944 Wound spray
08/07/2014US20140221455 Differentiation modulating agents and uses therefor
08/07/2014US20140221407 Use and application of a pharmaceutical composition containing a mixture of natural-origin heterocyclical guanidine, for cosmetology, wound healing, focal dystonia and muscular spasm- related clinical pathologies
08/07/2014US20140221326 Ophthalmologic irrigation solutions and method
08/07/2014US20140221292 Polyionic dendrimer and hydrogel comprising same
08/07/2014US20140221291 Compositions and Methods for Modulating Thrombin Generation
08/07/2014US20140221290 Stabilizing agent for pharmaceutical proteins
08/07/2014US20140221289 Thixotropic A-Lactalbumin Hydrogels, Method for Preparing Same and Uses Thereof
08/07/2014US20140221288 Methods for rapidly treating severe hypoglycemia
08/07/2014US20140221286 Sodium channel blockers reduce glucagon secretion
08/07/2014US20140221285 Stabilized pharmaceutical formulations of insulin analogues and/or insulin derivatives
08/07/2014US20140221283 Glucagon/glp-1 receptor co-agonists
08/07/2014US20140221282 Long duration dual hormone conjugates
08/07/2014US20140221281 Dual glp1/gip or trigonal glp1/gip/glucagon agonists
08/07/2014US20140221279 Regulation of energy metabolism and obesity by modulating a proliferation-inducing ligand (april) or april signaling
08/07/2014US20140221278 Disease treatment via antimicrobial peptides or their inhibitors
08/07/2014US20140221277 Method For Elevating Prolactin In Mammals
08/07/2014US20140221274 Low impurity content caspofungin preparation, method for preparing same, and use thereof
08/07/2014US20140221271 Shk-based pharmaceutical compositions and methods of manufacturing and using the same
08/07/2014US20140220676 Method and Medicament for Inhibiting the Expression of a Given Gene
08/07/2014US20140220600 Proteins expressed by mycobacterium tuberculosis and not by bcg and their use as diagnostic reagents and vaccines
08/07/2014US20140220159 HYDROGEN-BOND SURROGATE PEPTIDES AND PEPTIDOMIMETICS FOR p53 REACTIVATION
08/07/2014US20140220148 Diaminooxidase-containing pharmaceutical compositions
08/07/2014US20140220147 Pharmaceutical composition comprising factor vii encapsulated in micelles
08/07/2014US20140220134 Method for treating diabetes with extended release formulation of glp-1 receptor agonists
08/07/2014US20140220117 Cytotoxic T Lymphocyte Inducing Immunogens For Prevention Treatment and Diagnosis of Cancer
08/07/2014US20140220113 Method and Medicament for Inhibiting the Expression of a Given Gene
08/07/2014US20140220112 Transformation of drug cyclodextrin complex compositions into compositions of mixtures of lipid vesicle encapsulated drug and cyclodextrin drug complexes
08/07/2014US20140220111 Remote loading of sparingly water-soluble drugs into liposomes
08/07/2014US20140220110 Remote loading of sparingly water-soluble drugs into liposomes
08/07/2014US20140220109 Novel cochleate formulations
08/07/2014US20140220097 Method Of Implanting A Sterile, Active Agent-Coated Material And Composition Made According To Same
08/07/2014US20140220084 Use of plant cell membrane treatment of obesity
08/07/2014US20140220070 Use of plant cell membrane treatment of obesity
08/07/2014US20140220063 Vaccine composition
08/07/2014US20140220058 Vaccine composition for transdermal or mucosal administration
08/07/2014US20140220057 Wt1 peptide cancer vaccine composition for transdermal administration
08/07/2014US20140220055 Wt1 peptide cancer vaccine composition for transdermal administration
08/07/2014US20140220047 Monomethylvaline compounds capable of conjugation to ligands
08/07/2014US20140220037 Methods for treating reperfusion injuries
08/07/2014US20140220030 Use of cgrp antagonist compounds for treatment of psoriasis
08/07/2014US20140220029 Combined use of a modulator of cd3 and a glp-1 compound
08/07/2014US20140220025 Novel stip1 polypeptides and uses thereof
08/07/2014US20140220013 Method for the diagnosis and prognosis of malignant diseases
08/07/2014US20140220000 Mhc engagement and clip modulation for the treatment of disease
08/07/2014US20140219999 Treatment of colon cancer using complement inhibitors
08/07/2014US20140219992 Metal Sensitive Mutants of Matrix Metalloproteases and uses thereof
08/07/2014US20140219991 Treatment and composition for wound healing
08/07/2014US20140219990 Wound cleaning chemical composition and method for manufacturing
08/07/2014US20140219988 Rrecombinant human saposin b protein containing phosphorylated glucose ring and use thereof
08/07/2014US20140219987 Stabilized compositions of proteins having a free thiol moiety
08/07/2014US20140219986 Dosing regimens for the treatment of fabry disease
1 ... 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 ... 3163